A study published in the Journal of Diabetes and its Complications found that older adults with diabetes are more likely to ...

The efficacy of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy has been established in several controlled clinical trials. [17,18,19] These trials ...

Diabetic peripheral neuropathy, otherwise known as nerve pain, caused by diabetes, can have a severe impact on someone’s quality of life. This pain is often associated with tingling, numbness ...

Our results strongly suggest that the manipulation of glycosylation states of peripheral nociceptors ... would not only alleviate neuropathic pain in patients with diabetes but, even more ...

which is being developed as a first-in-class treatment for diabetic peripheral neuropathic pain (DPNP). This non-opioid candidate targets the AAK1 protein and has shown significant efficacy in ...

Along with LSR, Vertex is also running a trial of suzetrigine in painful diabetic peripheral neuropathy (DPN), another form of chronic, neuropathic pain. Commenting on the LSR data, principal ...

MulticEnter Study with an Open-label Extension in PatientS with Diabetic Peripheral Neuropathic Pain) study evaluating LX9211, a novel, orally-delivered, selective investigational small molecule ...

In July 2020, Grünenthal’s US subsidiary Averitas Pharma received US FDA approval for a QUTENZA (capsaicin) 8% patch for treating neuropathic pain associated with Diabetic Peripheral Neuropathy ...

Diabetic Foot Disease is defined as a syndrome in which peripheral neuropathy and peripheral vascular disease may result in foot ...